The Indian press reported that a Delhi-based ring sold fake cancer medicines in the U.S., China, and India. U.S. embassies and consulates in Mexico warned spring break travelers about counterfeit medicine. More domestic and international news about counterfeit medicines.
Read More
In spite of Etsy’s terms of use, there is a thriving trade in chemicals on the site, including those sold to individuals seeking homemade versions of highly regulated pharmaceuticals.
Read More
Colorado’s amended importation plan cuts prospective drugs by 78%. FDA Commissioner Califf warned about counterfeit medicines. A British couple who allegedly provided U.S. clinics they owned with illegally imported cancer medicines is facing extradition. Counterfeit medicine in Canada, Mexico and elsewhere.
Read More
Colorado’s updated Canadian drug importation application to the FDA cuts the drug list from 112 to 24 and adds Ozempic to the list of medicines it wants from Canadians.
Read More
The DEA put all e-commerce platforms on notice of their obligations whenever they facilitate transactions involving pill presses.
Read More
A Maryland drug distributor lost $2.7 million in a settlement over selling secondhand medicine to U.S. pharmacies. Additional news in Alabama, California, New Jersey, Tennessee and more.
Read More
Companies in New York and Florida were selling unapproved GLP-1 agonists. Operation Shield IV removed $69 million in illicit medicine and doping substances from European markets. A California man who distributed smuggled tianeptine received a two-year sentence.
Read More
PSM opposes the practice of reimbursing pharmacies below the cost of acquisition of medicine and supports efforts to reform reimbursement systems that eliminate this market dynamic that threatens the safety of our drug supply.
Read More
The government won prosecutions in Massachusetts and New Hampshire against defendants selling non-FDA approved drugs. A family warns about tianeptine. Pill presses in Texas, Virginia and West Virginia.
Read More
“We are deeply concerned about the impact importation of unapproved foreign prescription drugs will have on counterfeit medication in the United States, especially as FDA considers approving additional SIPs.”
Read More